Consequently, our findings suggest a potential mechanism wherein CCR7+/RELB+/IRF1+ triple positive T cells might induce osteoclast differentiation via cytokine production, particularly IL-17, as well as hyperactivation of non-canonical NF-kappaB signaling, contributing to bone damage in JIA patients. The gene discussed is IL17A; the disease is juvenile idiopathic arthritis.